Perron Institute of Neurological and Translational Sciences

Organization profile

Organisation profile

The Perron Institute for Neurological and Translational Science (formerly the Western Australian Neuroscience Research Institute – WANRI) is Western Australia’s longest established medical research institute. One of our special strengths is the depth of links between the institute’s laboratory research and its 15 specialist clinics. We undertake cutting edge research on a broad spectrum of conditions including stroke, Parkinson’s, muscular dystrophy and multiple sclerosis. This multidisciplinary approach enables us to translate research outcomes into treatments aimed at providing a better quality of life for millions of people around the world who suffer with devastating neurological conditions.

The Institute is affiliated with The University of Western Australia's Centre for Neuromuscular and Neurological Disorders.  The Centre's research publications are available in this repository via a search by Centre name.

 

Fingerprint Dive into the research topics where Perron Institute of Neurological and Translational Sciences is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Middle Cerebral Artery Infarction Medicine & Life Sciences
Arginine Medicine & Life Sciences
Peptides Medicine & Life Sciences
Oligodendroglia Medicine & Life Sciences
Stroke Medicine & Life Sciences
Multiple Sclerosis Medicine & Life Sciences
Neuroprotective Agents Medicine & Life Sciences
Long Noncoding RNA Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2019

Antisense-mediated splice intervention to treat human disease: the odyssey continues

Pitout, I., Flynn, L. L., Wilton, S. D. & Fletcher, S., 22 May 2019, In : F1000Research. 8, 710.

Research output: Contribution to journalReview article

Open Access
Oligonucleotides
Nucleic Acids
Pharmaceutical Preparations
Safety
Degradation

Exosomes-the enigmatic regulators of bone homeostasis (vol 6, 36, 2018)

Gao, M., Gao, W., Papadimitriou, J. M., Zhang, C., Gao, J. & Zheng, M., 25 Jan 2019, In : Bone Research. 7, 2 p., 3.

Research output: Contribution to journalArticle

Open Access

The effects of a combination of ion channel inhibitors on pathology in a model of demyelinating disease

Gopalasingam, G., Bartlett, C. A., McGonigle, T., Majimbi, M., Warnock, A., Ford, A., Gough, A., Toomey, L. M. & Fitzgerald, M., 1 Sep 2019, In : Multiple Sclerosis and Related Disorders. 34, p. 1-8 8 p.

Research output: Contribution to journalArticle

Oligodendroglia
Demyelinating Diseases
Ion Channels
Ranvier's Nodes
Cuprizone